THE IMPORTANCE OF DOSE AND DOSING REGIMEN OF ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) IN THE TREATMENT OF RHEUMATOID-ARTHRITIS (RA)

被引：0
|
作者：
CHOY, EHS
PITZALIS, C
BIJL, JA
KINGSLEY, GH
PANAYI, GS
机构：
[1] UMDS,GUYS HOSP,DIV MED,RHEUMATOL UNIT,LONDON,ENGLAND
[2] CENTOCOR INC,LEIDEN,NETHERLANDS
来源：
ARTHRITIS AND RHEUMATISM | 1993年 / 36卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [31] Repeat-cycle study of high-dose intravenous (iv) 4162W94 anti-CD4 monoclonal antibody (mAb) in rheumatoid arthritis (RA).
    Panavi, GS
    Choy, EHS
    Emery, P
    Madden, S
    Breedveld, FC
    Kraan, MC
    Kalden, JR
    Rascu, A
    Brown, JCC
    Johnston, JM
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S56 - S56
  • [32] IMMUNOLOGICAL EFFECTS OF HIGH-DOSE ADMINISTRATION OF ANTI-CD4 ANTIBODY IN RHEUMATOID-ARTHRITIS PATIENTS
    GOLDBERG, D
    MOREL, P
    CHATENOUD, L
    BOITARD, C
    MENKES, CJ
    BERTOYE, PH
    REVILLARD, JP
    BACH, JF
    JOURNAL OF AUTOIMMUNITY, 1991, 4 (04) : 617 - 630
  • [33] ANTI-CD4 MONOCLONAL-ANTIBODY FOR RELAPSING POLYCHONDRITIS
    VANDERLUBBE, PA
    MILTENBURG, AM
    BREEDVELD, FC
    LANCET, 1991, 337 (8753): : 1349 - 1349
  • [34] Anti-CD4 monoclonal antibodies in rheumatoid arthritis
    Choy, EHS
    Kingsley, GH
    Panayi, GS
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1998, 20 (1-2): : 261 - 273
  • [35] TREATMENT OF REFRACTORY RHEUMATOID-ARTHRITIS WITH A CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY - LONG-TERM FOLLOW-UP OF CD4+ T-CELL COUNTS
    MORELAND, LW
    PRATT, PW
    BUCY, RP
    JACKSON, BS
    FELDMAN, JW
    KOOPMAN, WJ
    ARTHRITIS AND RHEUMATISM, 1994, 37 (06): : 834 - 838
  • [36] TREATMENT OF SEVERE RHEUMATOID-ARTHRITIS BY ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODY
    WENDLING, D
    RACADOT, E
    WIJDENES, J
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (02) : 259 - 262
  • [37] Nondepleting humanized anti-CD4 monoclonal antibody in patients with refractory rheumatoid arthritis
    Moreland, LW
    Haverty, TP
    Wacholtz, MC
    Knowles, RW
    Bucy, RP
    Heck, LW
    Koopman, WJ
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (02) : 221 - 228
  • [38] TREATMENT OF INFLAMMATORY BOWEL-DISEASE WITH ANTI-CD4 MONOCLONAL-ANTIBODY
    EMMRICH, J
    SEYFARTH, M
    FLEIG, WE
    EMMRICH, F
    LANCET, 1991, 338 (8766): : 570 - 571
  • [39] MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
    DEKEYSER, F
    ELEWAUT, D
    MALFAIT, AM
    VEYS, E
    CLINICAL IMMUNOTHERAPEUTICS, 1994, 1 (02): : 148 - 156
  • [40] CLINICAL-RESPONSE OF RHEUMATOID-ARTHRITIS (RA) TO ANTI-TNF-ALPHA (CA2) MONOCLONAL-ANTIBODY (MAB) IS RELATED TO ADMINISTERED DOSE AND PERSISTENCE OF CIRCULATING ANTIBODY
    MAINI, RN
    ELLIOT, MJ
    LONGFOX, A
    FELDMANN, M
    KALDEN, JR
    ANTONIO, C
    SMOLEN, JS
    LEEB, B
    BREEDVELD, FC
    MACFARLANE, JD
    BIJL, H
    WOODY, JN
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 200 - 200
12345